Imaging Diagnostic CTLM(R) Presented at Recent International Breast Imaging Conference

Apr 11, 2001, 01:00 ET from Imaging Diagnostic Systems, Inc.

    FORT LAUDERDALE, Fla., April 11 /PRNewswire/ -- Imaging Diagnostic
 Systems, Inc. (OTC Bulletin Board:   IMDS) announced today that it has recently
 returned from Breast Imaging 2001 in Venice, Italy, where it exhibited its
 Computed Tomography Laser Mammography (CTLM)(R) system.
     The conference's focus was to provide the medical community with the
 innovations of breast cancer prevention, treatment, and new modalities such as
 digital mammography and digital ultrasound, and to explore the potential of
 three-dimensional imaging.
     Dr. David Richter, Medical Director for Imaging Diagnostic Systems was
 invited by Dr. Giorgio Rizzatto, the conference coordinator, to give a lecture
 on the potential benefits of CT laser Mammography in the Grand Hall to several
 radiologists, surgeons, gynecologists and other medical health care
 professionals last Thursday, April 5, 2001.
     "The importance of the lecture was to introduce a new technique to
 radiologists who were unfamiliar with this promising technology. The
 conference was highlighted by some of the most well-respected radiologists
 throughout the world which helped us a great deal in establishing some
 important relationships," stated Dr. Richter.
     Imaging Diagnostic Systems is seeking Pre-Market Approval (PMA) from the
 Food and Drug Administration (FDA) for its CTLM(R) system to be used as an
 adjunct to mammography to aid in the detection of breast abnormalities. Under
 the new Modular submission approach, the Company's PMA application has been
 divided into different modules, each of which will contain documentation
 required for the FDA review.  The Company has submitted two modules and is
 currently completing the next set of modules to be submitted.
     Imaging Diagnostic Systems, Inc. has developed the world's first patented
 laser-based breast imaging system that utilizes state-of-the-art laser
 technology and proprietary and patented algorithms to create three-dimensional
 cross sectional images of the breast.  The CTLM(R) is a non-invasive, painless
 examination that does not expose the patient to radiation or require breast
 compression.
 
     In conjunction with the provisions of the Safe Harbor section of the
 Private Securities Litigation Reform Act of 1995, this news release may
 contain forward-looking statements pertaining to future anticipated projected
 plans, performances and developments, as well as other statements relating
 future operations.  All such forward-looking statements are necessarily only
 estimates of future results and there can be no assurance that actual results
 will not materially differ from expectation.  Further information on potential
 factors that could affect Imaging Diagnostic Systems, Inc. is included in the
 Company's filing with the Securities Exchange Commission.
     Interested persons are encouraged to visit the Company's Web site
 www.imds.com.
 
     Imaging Diagnostic Systems, Inc.
     Deborah O'Brien, VP of Corporate Communications
     954-581-9800
 
     Public Relations
     Margie Adelman
     561-620-7440
     Margie10@hotmail.com
 
 

SOURCE Imaging Diagnostic Systems, Inc.
    FORT LAUDERDALE, Fla., April 11 /PRNewswire/ -- Imaging Diagnostic
 Systems, Inc. (OTC Bulletin Board:   IMDS) announced today that it has recently
 returned from Breast Imaging 2001 in Venice, Italy, where it exhibited its
 Computed Tomography Laser Mammography (CTLM)(R) system.
     The conference's focus was to provide the medical community with the
 innovations of breast cancer prevention, treatment, and new modalities such as
 digital mammography and digital ultrasound, and to explore the potential of
 three-dimensional imaging.
     Dr. David Richter, Medical Director for Imaging Diagnostic Systems was
 invited by Dr. Giorgio Rizzatto, the conference coordinator, to give a lecture
 on the potential benefits of CT laser Mammography in the Grand Hall to several
 radiologists, surgeons, gynecologists and other medical health care
 professionals last Thursday, April 5, 2001.
     "The importance of the lecture was to introduce a new technique to
 radiologists who were unfamiliar with this promising technology. The
 conference was highlighted by some of the most well-respected radiologists
 throughout the world which helped us a great deal in establishing some
 important relationships," stated Dr. Richter.
     Imaging Diagnostic Systems is seeking Pre-Market Approval (PMA) from the
 Food and Drug Administration (FDA) for its CTLM(R) system to be used as an
 adjunct to mammography to aid in the detection of breast abnormalities. Under
 the new Modular submission approach, the Company's PMA application has been
 divided into different modules, each of which will contain documentation
 required for the FDA review.  The Company has submitted two modules and is
 currently completing the next set of modules to be submitted.
     Imaging Diagnostic Systems, Inc. has developed the world's first patented
 laser-based breast imaging system that utilizes state-of-the-art laser
 technology and proprietary and patented algorithms to create three-dimensional
 cross sectional images of the breast.  The CTLM(R) is a non-invasive, painless
 examination that does not expose the patient to radiation or require breast
 compression.
 
     In conjunction with the provisions of the Safe Harbor section of the
 Private Securities Litigation Reform Act of 1995, this news release may
 contain forward-looking statements pertaining to future anticipated projected
 plans, performances and developments, as well as other statements relating
 future operations.  All such forward-looking statements are necessarily only
 estimates of future results and there can be no assurance that actual results
 will not materially differ from expectation.  Further information on potential
 factors that could affect Imaging Diagnostic Systems, Inc. is included in the
 Company's filing with the Securities Exchange Commission.
     Interested persons are encouraged to visit the Company's Web site
 www.imds.com.
 
     Imaging Diagnostic Systems, Inc.
     Deborah O'Brien, VP of Corporate Communications
     954-581-9800
 
     Public Relations
     Margie Adelman
     561-620-7440
     Margie10@hotmail.com
 
 SOURCE  Imaging Diagnostic Systems, Inc.